beizray
Generic: docetaxel
Labeler: zydus pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
beizray
Generic Name
docetaxel
Labeler
zydus pharmaceuticals usa inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
docetaxel anhydrous 20 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70710-2152
Product ID
70710-2152_4efe8f3a-a176-4b69-90c8-5ba5891dccfd
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA218711
Listing Expiration
2026-12-31
Marketing Start
2025-08-28
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
707102152
Hyphenated Format
70710-2152
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
beizray (source: ndc)
Generic Name
docetaxel (source: ndc)
Application Number
NDA218711 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/mL
Packaging
- 1 VIAL, GLASS in 1 CARTON (70710-2152-1) / 4 mL in 1 VIAL, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "4efe8f3a-a176-4b69-90c8-5ba5891dccfd", "openfda": {"nui": ["N0000175085", "N0000175592"], "unii": ["699121PHCA"], "rxcui": ["1860480", "1860485", "2054168", "2054170", "2697044", "2723663", "2723664", "2723665", "2723666", "2728902"], "spl_set_id": ["8fb7d980-d6c7-468b-a9f0-adff16101a4b"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 VIAL, GLASS in 1 CARTON (70710-2152-1) / 4 mL in 1 VIAL, GLASS", "package_ndc": "70710-2152-1", "marketing_start_date": "20250828"}], "brand_name": "BEIZRAY", "product_id": "70710-2152_4efe8f3a-a176-4b69-90c8-5ba5891dccfd", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "70710-2152", "generic_name": "Docetaxel", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BEIZRAY", "active_ingredients": [{"name": "DOCETAXEL ANHYDROUS", "strength": "20 mg/mL"}], "application_number": "NDA218711", "marketing_category": "NDA", "marketing_start_date": "20250828", "listing_expiration_date": "20261231"}